Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity

Creative Commons License

Shkodra-Pula B., Kretzer C., Jordan P. M., Klemm P., Koeberle A., Pretzel D., ...Daha Fazla

JOURNAL OF NANOBIOTECHNOLOGY, cilt.18, sa.1, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1186/s12951-020-00620-7
  • Dergi Adı: JOURNAL OF NANOBIOTECHNOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Compendex, EMBASE, INSPEC, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Anahtar Kelimeler: Acetalated dextran, PLGA, Nanoparticles, Leukotriene biosynthesis, FLAP inhibitor, MPGES-1, Dual inhibitor, BRP-187, PROSTAGLANDIN-E SYNTHASE-1, LEUKOTRIENE BIOSYNTHESIS, DRUG-DELIVERY, POLYMERS, RELEASE, NANOPRECIPITATION, 5-LIPOXYGENASE, MICROPARTICLES, PRODUCTS, SURFACE
  • Gazi Üniversitesi Adresli: Evet

Özet

Background Dual inhibitors of the 5-lipoxygenase-activating protein (FLAP) and the microsomal prostaglandin E-2 synthase-1 (mPGES-1) may exert better anti-inflammatory efficacy and lower risks of adverse effects versus non-steroidal anti-inflammatory drugs. Despite these advantages, many dual FLAP/mPGES-1 inhibitors are acidic lipophilic molecules with low solubility and strong tendency for plasma protein binding that limit their bioavailability and bioactivity. Here, we present the encapsulation of the dual FLAP/mPGES-1 inhibitor BRP-187 into the biocompatible polymers acetalated dextran (Acdex) and poly(lactic-co-glycolic acid) (PLGA) via nanoprecipitation. Results The nanoparticles containing BRP-187 were prepared by the nanoprecipitation method and analyzed by dynamic light scattering regarding their hydrodynamic diameter, by scanning electron microscopy for morphology properties, and by UV-VIS spectroscopy for determination of the encapsulation efficiency of the drug. Moreover, we designed fluorescent BRP-187 particles, which showed high cellular uptake by leukocytes, as analyzed by flow cytometry. Finally, BRP-187 nanoparticles were tested in human polymorphonuclear leukocytes and macrophages to determine drug uptake, cytotoxicity, and efficiency to inhibit FLAP and mPGES-1. Conclusion Our results demonstrate that encapsulation of BRP-187 into Acdex and PLGA is feasible, and both PLGA- and Acdex-based particles loaded with BRP-187 are more efficient in suppressing 5-lipoxygenase product formation and prostaglandin E-2 biosynthesis in intact cells as compared to the free compound, particularly after prolonged preincubation periods.